Isatuximab, pomalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: the Italian, multicenter, retrospective clinical experience with 270 cases outside of controlled clinical trials
Not available.
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2024-11-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/11854 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846150436962172928 |
|---|---|
| author | Enrica Antonia Martino Daniele Derudas Elena Rossi Sofia Terlizzi Giovanni Reddiconto Paola Stefanoni Jacopo Micozzi Silvia Mangiacavalli Elena Zamagni Massimo Offidani Anna Furlan Gabriele Buda Flavia Lotti Carmine Liberatore Antonio Lazzaro Roberta Della Pepa Giuseppe Bertuglia Emiliano Barbieri Concetta Conticello Claudio De Magistris Lorenzo De Paoli Velia Bongarzoni Anna Maria Cafro Anna Mele Pietro Benvenuti Claudio Cerchione Cirino Botta Elisabetta Antonioli Nicola Sgherza Sara Aquino Giuseppe Mele Gregorio Barilà Salvatore Palmieri Ombretta Annibali Rosario Bianco Massimiliano Arangio Febbo Gloria Margiotta Casaluci Angela Rago Raffaele Fontana Francesca Farina Ernesto Vigna Antonella Bruzzese Katia Mancuso Davide Nappi Sonia Morè Elena Rivolti Catello Califano Angela Amendola Daniela Roccotelli Alessandra Lombardo Annalisa Citro Giuseppina Uccello Renato Zambello Alessandro Maggi Santo Neri Michele Monachesi Alessandro Gozzetti Vittorio Montefusco Marino Brunori Emilia Cotzia Giuseppe Pietrantuono Angela Maria Quinto Valeria Amico Nicola Di Renzo Marta Coscia Monica Galli Valerio De Stefano Maria Teresa Petrucci Antonino Neri Francesco Di Raimondo Fortunato Morabito Pellegrino Musto Massimo Gentile |
| author_facet | Enrica Antonia Martino Daniele Derudas Elena Rossi Sofia Terlizzi Giovanni Reddiconto Paola Stefanoni Jacopo Micozzi Silvia Mangiacavalli Elena Zamagni Massimo Offidani Anna Furlan Gabriele Buda Flavia Lotti Carmine Liberatore Antonio Lazzaro Roberta Della Pepa Giuseppe Bertuglia Emiliano Barbieri Concetta Conticello Claudio De Magistris Lorenzo De Paoli Velia Bongarzoni Anna Maria Cafro Anna Mele Pietro Benvenuti Claudio Cerchione Cirino Botta Elisabetta Antonioli Nicola Sgherza Sara Aquino Giuseppe Mele Gregorio Barilà Salvatore Palmieri Ombretta Annibali Rosario Bianco Massimiliano Arangio Febbo Gloria Margiotta Casaluci Angela Rago Raffaele Fontana Francesca Farina Ernesto Vigna Antonella Bruzzese Katia Mancuso Davide Nappi Sonia Morè Elena Rivolti Catello Califano Angela Amendola Daniela Roccotelli Alessandra Lombardo Annalisa Citro Giuseppina Uccello Renato Zambello Alessandro Maggi Santo Neri Michele Monachesi Alessandro Gozzetti Vittorio Montefusco Marino Brunori Emilia Cotzia Giuseppe Pietrantuono Angela Maria Quinto Valeria Amico Nicola Di Renzo Marta Coscia Monica Galli Valerio De Stefano Maria Teresa Petrucci Antonino Neri Francesco Di Raimondo Fortunato Morabito Pellegrino Musto Massimo Gentile |
| author_sort | Enrica Antonia Martino |
| collection | DOAJ |
| description |
Not available.
|
| format | Article |
| id | doaj-art-0b34d4c37c83440ca5f3ab97b94ba9cd |
| institution | Kabale University |
| issn | 0390-6078 1592-8721 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | Ferrata Storti Foundation |
| record_format | Article |
| series | Haematologica |
| spelling | doaj-art-0b34d4c37c83440ca5f3ab97b94ba9cd2024-11-28T19:42:31ZengFerrata Storti FoundationHaematologica0390-60781592-87212024-11-01999110.3324/haematol.2024.286658Isatuximab, pomalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: the Italian, multicenter, retrospective clinical experience with 270 cases outside of controlled clinical trialsEnrica Antonia Martino0Daniele Derudas1Elena Rossi2Sofia Terlizzi3Giovanni Reddiconto4Paola Stefanoni5Jacopo Micozzi6Silvia Mangiacavalli7Elena Zamagni8Massimo Offidani9Anna Furlan10Gabriele Buda11Flavia Lotti12Carmine Liberatore13Antonio Lazzaro14Roberta Della Pepa15Giuseppe Bertuglia16Emiliano Barbieri17Concetta Conticello18Claudio De Magistris19Lorenzo De Paoli20Velia Bongarzoni21Anna Maria Cafro22Anna Mele23Pietro Benvenuti24Claudio Cerchione25Cirino Botta26Elisabetta Antonioli27Nicola Sgherza28Sara Aquino29Giuseppe Mele30Gregorio Barilà31Salvatore Palmieri32Ombretta Annibali33Rosario Bianco34Massimiliano Arangio Febbo35Gloria Margiotta Casaluci36Angela Rago37Raffaele Fontana38Francesca Farina39Ernesto Vigna40Antonella Bruzzese41Katia Mancuso42Davide Nappi43Sonia Morè44Elena Rivolti45Catello Califano46Angela Amendola47Daniela Roccotelli48Alessandra Lombardo49Annalisa Citro50Giuseppina Uccello51Renato Zambello52Alessandro Maggi53Santo Neri54Michele Monachesi55Alessandro Gozzetti56Vittorio Montefusco57Marino Brunori58Emilia Cotzia59Giuseppe Pietrantuono60Angela Maria Quinto61Valeria Amico62Nicola Di Renzo63Marta Coscia64Monica Galli65Valerio De Stefano66Maria Teresa Petrucci67Antonino Neri68Francesco Di Raimondo69Fortunato Morabito70Pellegrino Musto71Massimo Gentile72Department of Onco-hematology, Hematology Unit, Azienda Ospedaliera Annunziata, CosenzaDepartment of Hematology, Businco Hospital, CagliariSection of Hematology, Catholic University, Fondazione Policlinico Gemelli IRCCS, RomeDepartment of Hematology ASST Spedali Civili di Brescia, BresciaDepartment of Hematology, Hospital Vito Fazzi, LecceHematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, BergamoDepartment of Translational and Precision Medicine, Hematology Azienda Policlinico Umberto I Sapienza University of Rome, RomeDivision of Hematology, IRCCS Fondazione Policlinico San Matteo, PaviaIRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy; Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, BolognaHematology Unit, AOU delle Marche, AnconaDivision of Hematology Ospedale Ca' Foncello di Treviso, ASL 2, TrevisoDepartment of Clinical and Experimental Medicine, Hematology, University of Pisa, PisaInstitute of Hematology, TMO Azienda Universitaria-Ospedaliera Santa Maria della Misericordia di Perugia, PerugiaHematology Unit, Department of Oncology and Hematology, Ospedale Santo Spirito, Pescara, Italy; Department of Medicine and Aging Sciences, University of Chieti-Pescara, ChietiDivision of Hematology and Bone Marrow Transplant Center, Hospital Guglielmo da Saliceto, PiacenzaDepartment of Clinical Medicine and Surgery, University Federico II, NaplesDivision of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, University of Torino, TorinoHematology Unit, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio EmiliaDivision of Hematology, Azienda Policlinico-S. Marco, University of Catania, CataniaHematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, MilanDivision of Hematology, Ospedale Sant’Andrea, VercelliUOC of Hematology San Giovanni-Addolorata Hospital Rome ItalyDepartment of Hematology, GOM Niguarda Hospital, MilanHaematology, Ospedale Cardinale Panico, Tricase (Lecce)Department of Medicine and Surgery, University of Insubria and Department of Oncology, ASST Sette Laghi, Ospedale di Circolo, VareseDepartment of Hematology, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Meldola, Forlì-CesenaDepartment of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, PalermoHaematology Unit Careggi University Hospital, FlorenceUnit of Hematology and Stem Cell Transplantation, AOUC Policlinico, BariHematology and Hematopoietic Stem Cell Transplantation Unit, IRCCS Ospedale Policlinico San Martino, GenoaDepartment of Hematology, Hospital Perrino, BrindisiHematology Unit, Ospedale San Bortolo, VicenzaHematology Unit, Ospedale Cardarelli, NapoliHematology, stem cell transplantation, Fondazione Policlinico Universitario Campus Bio medico di Roma, RomeHematology, Hospital "Sant'Anna e San Sebastiano", CasertaOnco Hematology Unit, Veneto Institute of Oncology IOV-IRCCS, PaduaDivision of Hematology, Department of Translational Medicine, University of Eastern Piedmont, NovaraUOSD Ematologia ASL Roma 1, RomeHematology and Transplant Center, University Hospital "San Giovanni di Dio e Ruggi d'Aragona", SalernoHematology and BMT Unit, IRCCS Ospedale San Raffaele, MilanDepartment of Onco-hematology, Hematology Unit, Azienda Ospedaliera Annunziata, CosenzaDepartment of Onco-hematology, Hematology Unit, Azienda Ospedaliera Annunziata, CosenzaIRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy; Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, BolognaDepartment of Medicine and Surgery, University of Insubria and Department of Oncology, ASST Sette Laghi, Ospedale di Circolo, VareseHematology Unit, AOU delle Marche, AnconaHematology Unit, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio EmiliaOnco- Hematology Unit, "A. Tortora" Hospital, PaganiHematology Unit, Azienda Ospedaliera Regionale "San Carlo", PotenzaDepartment of Hematology and Bone Marrow Transplant, IRCSS Casa Sollievo Della Sofferenza, San Giovanni RotondoOnco-hematology Unit Azienda Ospedaliera Santa Maria of Terni, TerniHematology Unit, Legnano General Hospital, Legnano (Milan)Hematology Unit, Azienda Ospedaliera di Rilievo Nazionale e di Alta Specializzazione (ARNAS) Garibaldi, CataniaDepartment of Medicine (DIMED), Hematology and Clinical Immunology, Padua University School of Medicine, PadovaHaematology, Ospedale G. Moscati, TarantoHematology Unit, Azienda Ospedaliera Papardo, MessinaInstitute of Hematology, TMO Azienda Universitaria-Ospedaliera Santa Maria della Misericordia di Perugia, PerugiaDepartment of Medicine, Surgery and Neurosciences, University of Siena Policlinico S Maria alle Scotte, SienaDivision of Hematology, Azienda Socio Sanitaria Territoriale (ASST) Santi Paolo e Carlo, MilanInternal Medicine, Ospedale Santa Croce, FanoSection of Hematology- Ospedale E. Muscatello-Augusta, SiracusaIRCCS CROB, Referral Cancer Center of Basilicata, Rionero In VultureHaematology and Transplant Unit, IRCCS - Istituto Tumori "Giovanni Paolo II", BariUOSD Ematologia, AORN San Pio, BeneventoDepartment of Hematology, Hospital Vito Fazzi, LecceHaematology, Ospedale Cardinale Panico, Tricase (Lecce)Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, BergamoSection of Hematology, Catholic University, Fondazione Policlinico Gemelli IRCCS, RomeDepartment of Translational and Precision Medicine, Hematology Azienda Policlinico Umberto I Sapienza University of Rome, RomeScientific Directorate, Azienda USL-IRCCS di Reggio EmiliaHematology Unit, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio EmiliaGruppo Amici Dell'Ematologia Foundation-GrADE, Reggio EmiliaHaematology Unit Careggi University Hospital, Florence, Italy; Department of Precision and Regenerative Medicine and Ionian Area, "Aldo Moro" University School of Medicine, BariDepartment of Onco-hematology, Hematology Unit, Azienda Ospedaliera Annunziata, Cosenza, Italy; Department of Pharmacy, Health and Nutritional Science, University of Calabria, Rende Not available. https://haematologica.org/article/view/11854 |
| spellingShingle | Enrica Antonia Martino Daniele Derudas Elena Rossi Sofia Terlizzi Giovanni Reddiconto Paola Stefanoni Jacopo Micozzi Silvia Mangiacavalli Elena Zamagni Massimo Offidani Anna Furlan Gabriele Buda Flavia Lotti Carmine Liberatore Antonio Lazzaro Roberta Della Pepa Giuseppe Bertuglia Emiliano Barbieri Concetta Conticello Claudio De Magistris Lorenzo De Paoli Velia Bongarzoni Anna Maria Cafro Anna Mele Pietro Benvenuti Claudio Cerchione Cirino Botta Elisabetta Antonioli Nicola Sgherza Sara Aquino Giuseppe Mele Gregorio Barilà Salvatore Palmieri Ombretta Annibali Rosario Bianco Massimiliano Arangio Febbo Gloria Margiotta Casaluci Angela Rago Raffaele Fontana Francesca Farina Ernesto Vigna Antonella Bruzzese Katia Mancuso Davide Nappi Sonia Morè Elena Rivolti Catello Califano Angela Amendola Daniela Roccotelli Alessandra Lombardo Annalisa Citro Giuseppina Uccello Renato Zambello Alessandro Maggi Santo Neri Michele Monachesi Alessandro Gozzetti Vittorio Montefusco Marino Brunori Emilia Cotzia Giuseppe Pietrantuono Angela Maria Quinto Valeria Amico Nicola Di Renzo Marta Coscia Monica Galli Valerio De Stefano Maria Teresa Petrucci Antonino Neri Francesco Di Raimondo Fortunato Morabito Pellegrino Musto Massimo Gentile Isatuximab, pomalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: the Italian, multicenter, retrospective clinical experience with 270 cases outside of controlled clinical trials Haematologica |
| title | Isatuximab, pomalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: the Italian, multicenter, retrospective clinical experience with 270 cases outside of controlled clinical trials |
| title_full | Isatuximab, pomalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: the Italian, multicenter, retrospective clinical experience with 270 cases outside of controlled clinical trials |
| title_fullStr | Isatuximab, pomalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: the Italian, multicenter, retrospective clinical experience with 270 cases outside of controlled clinical trials |
| title_full_unstemmed | Isatuximab, pomalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: the Italian, multicenter, retrospective clinical experience with 270 cases outside of controlled clinical trials |
| title_short | Isatuximab, pomalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: the Italian, multicenter, retrospective clinical experience with 270 cases outside of controlled clinical trials |
| title_sort | isatuximab pomalidomide and dexamethasone as salvage therapy for patients with multiple myeloma the italian multicenter retrospective clinical experience with 270 cases outside of controlled clinical trials |
| url | https://haematologica.org/article/view/11854 |
| work_keys_str_mv | AT enricaantoniamartino isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT danielederudas isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT elenarossi isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT sofiaterlizzi isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT giovannireddiconto isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT paolastefanoni isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT jacopomicozzi isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT silviamangiacavalli isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT elenazamagni isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT massimooffidani isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT annafurlan isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT gabrielebuda isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT flavialotti isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT carmineliberatore isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT antoniolazzaro isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT robertadellapepa isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT giuseppebertuglia isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT emilianobarbieri isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT concettaconticello isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT claudiodemagistris isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT lorenzodepaoli isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT veliabongarzoni isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT annamariacafro isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT annamele isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT pietrobenvenuti isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT claudiocerchione isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT cirinobotta isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT elisabettaantonioli isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT nicolasgherza isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT saraaquino isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT giuseppemele isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT gregoriobarila isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT salvatorepalmieri isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT ombrettaannibali isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT rosariobianco isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT massimilianoarangiofebbo isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT gloriamargiottacasaluci isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT angelarago isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT raffaelefontana isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT francescafarina isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT ernestovigna isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT antonellabruzzese isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT katiamancuso isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT davidenappi isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT soniamore isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT elenarivolti isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT catellocalifano isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT angelaamendola isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT danielaroccotelli isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT alessandralombardo isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT annalisacitro isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT giuseppinauccello isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT renatozambello isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT alessandromaggi isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT santoneri isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT michelemonachesi isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT alessandrogozzetti isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT vittoriomontefusco isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT marinobrunori isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT emiliacotzia isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT giuseppepietrantuono isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT angelamariaquinto isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT valeriaamico isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT nicoladirenzo isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT martacoscia isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT monicagalli isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT valeriodestefano isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT mariateresapetrucci isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT antoninoneri isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT francescodiraimondo isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT fortunatomorabito isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT pellegrinomusto isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials AT massimogentile isatuximabpomalidomideanddexamethasoneassalvagetherapyforpatientswithmultiplemyelomatheitalianmulticenterretrospectiveclinicalexperiencewith270casesoutsideofcontrolledclinicaltrials |